Remove Healthcare Remove PET Scan Remove Radiopharmaceuticals
article thumbnail

First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies

Imaging Technology

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Fruhwirth, G. Kneilling, M., De Vries, I. Weigelin, B.,

article thumbnail

GE HealthCare and Axim Life Isotopes South Africa (ALISA) Collaborate to Expand Access to Molecular Imaging in South Africa and Drive Precision Care

Imaging Technology

GE HealthCare has signed an agreement with Axim Life Isotopes South Africa (Pty) Ltd. GE HealthCare will deliver the Cyclotrons to ALISA’s laboratory facility in Midrand, South Africa early next year, giving patients in Africa access to medical advancements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the Minnies 2024 semifinal candidates

AuntMinnie

tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PET scans predict patient response to Pluvicto.

article thumbnail

Unlocking the potential of imaging in Alzheimer’s disease care

AuntMinnie

Alzheimer’s has been a formidable challenge for our society, patients, caregivers, and healthcare systems for decades. Additionally, an increasing aging population has further exacerbated the burden of this disease on healthcare systems. Beyond coverage, improved payment policies can help increase access to PET scans as well.

Disease 130